Maze Therapeutics, Inc. (MAZE)
22.52
-0.92
(-3.92%)
USD |
NASDAQ |
Sep 18, 16:00
22.61
+0.09
(+0.40%)
After-Hours: 20:00
Maze Therapeutics Price to Book Value : 2.758 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.758 |
| September 17, 2026 | 2.871 |
| September 16, 2026 | 2.929 |
| September 15, 2026 | 2.968 |
| September 14, 2026 | 3.022 |
| September 11, 2026 | 3.013 |
| September 10, 2026 | 3.040 |
| September 09, 2026 | 3.011 |
| September 08, 2026 | 3.230 |
| September 04, 2026 | 3.210 |
| September 03, 2026 | 3.169 |
| September 02, 2026 | 3.273 |
| September 01, 2026 | 3.250 |
| August 31, 2026 | 3.255 |
| August 28, 2026 | 3.361 |
| August 27, 2026 | 3.503 |
| August 26, 2026 | 3.623 |
| August 25, 2026 | 3.726 |
| August 24, 2026 | 3.626 |
| August 21, 2026 | 3.605 |
| August 20, 2026 | 3.544 |
| August 19, 2026 | 3.644 |
| August 18, 2026 | 3.568 |
| August 17, 2026 | 3.424 |
| August 14, 2026 | 3.329 |
| Date | Value |
|---|---|
| August 13, 2026 | 3.389 |
| August 12, 2026 | 3.372 |
| August 11, 2026 | 3.345 |
| August 10, 2026 | 3.342 |
| August 07, 2026 | 3.509 |
| August 06, 2026 | 3.495 |
| August 05, 2026 | 3.406 |
| August 04, 2026 | 3.382 |
| August 03, 2026 | 3.348 |
| July 31, 2026 | 3.298 |
| July 30, 2026 | 3.384 |
| July 29, 2026 | 3.340 |
| July 28, 2026 | 3.415 |
| July 27, 2026 | 3.514 |
| July 24, 2026 | 3.391 |
| July 23, 2026 | 3.392 |
| July 22, 2026 | 3.490 |
| July 21, 2026 | 3.589 |
| July 20, 2026 | 3.475 |
| July 17, 2026 | 3.444 |
| July 16, 2026 | 3.328 |
| July 15, 2026 | 3.600 |
| July 14, 2026 | 3.660 |
| July 13, 2026 | 3.574 |
| July 10, 2026 | 3.745 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.929 |
| Corcept Therapeutics, Inc. | 16.86 |
| Veru, Inc. | 1.448 |
| Johnson & Johnson | 7.652 |
| Eli Lilly & Co. | 32.04 |
Price to Book Value Related Metrics
| PS Ratio | 59.20 |
| PEG Ratio | -0.1761 |
| Price | 22.52 |
| Earnings Yield | -11.25% |
| Market Cap | 1.250B |
| PEGY Ratio | -0.1761 |